Emerging role of bacteria in oral carcinogenesis: A review with special reference to perio-pathogenic bacteria

Journal of Oral Microbiology

Volumn 8, Issue 1, 2016, Pages

  Perera, Manosha ^a   Al Hebshi, Nezar Noor ^b,c   Speicher, David J ^a   Perera, Irosha ^d   Johnson, Newell W ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c TEMPLE UNIVERSITY   (United States)

^d Dental Institute   (Sri Lanka)

Author keywords

Bacteria; Carcinoma; Dysbiosis; Inflammation; Microbiome; Mouth; Squamous cell

Indexed keywords

APOPTOSIS; BACTERIUM; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DYSBIOSIS; HUMAN; INFLAMMATION; MICROBIOME; MOUTH EPITHELIUM CELL; MOUTH FLORA; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; REVIEW; RISK FACTOR;

EID: 85011067260     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v8.32762     Document Type: Review

References (96)

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-16.
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer.
3. Silverman S. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001; 132: 7S-11S.
4. Alfano MC, Horowitz AM. Professional and community efforts to prevent morbidity and mortality from oral cancer. JAm Dent Assoc 2001; 132: 24S-9S.
5. Wang B, Zhang S, Yue K, Wang XD. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer 2013; 32: 614-18.
6. Vazquez-Mahia I, Seoane J, Varela-Centelles P, Tomas I, Alvarez Garcia A, Lopez Cedrun JL. Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg 2012; 70: 1724-32.
7. Petti S. Lifestyle risk factors for oral cancer. Oral Oncol 2009; 45: 340-50.
8. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens-part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 1033-4.
9. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32: 59-66.
10. Gupta B, Johnson NW. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One 2014; 9: e113385.
11. Petersen PE. Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol 2009; 45: 454-60.
12. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral oncol 2004; 40: 304-13.
13. Llewellyn C, Johnson NW, Warnakulasuriya K. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med 2004; 33: 525-32.
14. Bleyer A, editor. Cancer of the oral cavity and pharynx in young females: increasing incidence, role of human papilloma virus, and lack of survival improvement. Semin Oncol 2009; 36: 451-9.
15. Kietthubthew S, Sriplung H, Au WW, Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 2006; 209: 21-9.
16. Bau D, Tsai M, Huang C, Lee C, Tseng H, Lo Y, et al. Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chin J Physiol 2007; 50: 294.
17. Hatagima A, Costa EC, Marques CF, Koifman RJ, Boffetta P, Koifman S. Glutathione S-transferase polymorphisms and oral cancer: a case-control study in Rio de Janeiro, Brazil. Oral Oncol 2008; 44: 200-7.
18. Thornhill MH. The sun, the ozone layer and the skin: the role of ultraviolet light in lip and skin cancer. Dent Update 1993; 20: 236-40.
19. Kumar SKS, Zain RB. Aetiology and risk factors for oral cancer-a brief overview. Annal Dent Univ Malaya 2004; 11: 41-50.
20. Meyer MS, Joshipura K, Giovannucci E, Michaud DS. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 2008; 19: 895-907.
21. Hayashi C, Gudino C, Gibson F III, Genco C. Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol 2010; 25: 305-16.
22. Chocolatewala N, Chaturvedi P, Desale R. The role of bacteria in oral cancer. Indian J Med Paediatr Oncol 2010; 31: 126.
23. Mager D. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med 2006; 4: 14.
24. Markowska J, Fischer N, Markowski M, Nalewaj J. The role of Chlamydia trachomatis infection in the development of cervical neoplasia and carcinoma. Med Wieku Rozwoj 2005; 9: 83-6.
25. Nagaraja V, Eslick G. Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther 2014; 39: 745-50. doi: http://dx.doi.org/10.1111/apt.12655
26. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-8.
27. Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006; 12: 782-6.
28. Meurman JH. Oral microbiota and cancer. J Oral Microbiol 2010; 2, 5195, doi: http://dx.doi.org/10.3402/jom.v2i0.5195
29. Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog 2014; 10: e1003933.
30. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck 2009; 31: 1228-39.
31. Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis 2014; 35: 249-55.
32. Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe 2011; 10: 324-35.
33. Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J 2013; 27: 1012-22.
34. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-14.
35. Gill SR, PopM, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-9.
36. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett C, Knight R, Gordon JI. The human microbiome project: exploring the microbial part of ourselves in a changing world. Nature 2007; 449: 804.
37. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, et al. The human oral microbiome. J Bacteriol 2010; 192: 5002-17.
38. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005; 43: 5721-32.
39. Do T, Devine D, Marsh PD. Oral biofilms: molecular analysis, challenges, and future prospects in dental diagnostics. Clin Cosmet Investig Dent 2013; 5: 11-19.
40. Zarco MF, Vess TJ, Ginsburg GS. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 2012; 18: 109-20.
41. Chen T, Yu W-H, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database 2010; 2010: baq013.
42. Sakamoto M, Umeda M, Benno Y. Molecular analysis of human oral microbiota. J Periodontal Res 2005; 40: 277-85.
43. Siqueira JF Jr., Fouad AF, Rocas IN. Pyrosequencing as a tool for better understanding of human microbiomes. J Oral Microbiol 2012; 4, 10743, doi: http://dx.doi.org/10.3402/jom. v4i0.10743
44. Parahitiyawa N, Scully C, Leung W, Yam W, Jin L, Samaranayake L. Exploring the oral bacterial flora: current status and future directions. Oral Dis 2010; 16: 136-45.
45. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010; 8: 481-90.
46. Takahashi N, Nyvad B. The role of bacteria in the caries process: ecological perspectives. J Dent Res 2011; 90: 294-303.
47. Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 2010; 8: 471-80.
48. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25: 134-44.
49. Al-Hebshi NN, Al-Alimi A, Taiyeb-Ali T, Jaafar N. Quantitative analysis of classical and new putative periodontal pathogens in subgingival biofilm: a case-control study. J Periodontal Res 2015; 50: 320-9.
50. Nagy K, Sonkodi I, Szöke I, Nagy E, Newman H. The microflora associated with human oral carcinomas. Oral Oncol 1998; 34: 304-8.
51. Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int J Oral Sci 2011; 3: 209-15.
52. Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 2012; 33: 1055-8.
53. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306.
54. Michaud DS, Izard J. Microbiota, oral microbiome, and pancreatic cancer. Cancer J 2014; 20: 203-6.
55. Tateda M, Shiga K, Saijo S, Sone M, Hori T, Yokoyama J, et al. Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. Int J Mol Med 2000; 6: 699-703.
56. Sasaki M, Yamaura C, Ohara-Nemoto Y, Tajika S, Kodama Y, Ohya T, et al. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis 2005; 11: 151-6.
57. Morita E, Narikiyo M, Yano A, Nishimura E, Igaki H, Sasaki H, et al. Different frequencies of Streptococcus anginosus infection in oral cancer and esophageal cancer. Cancer Sci 2003; 94: 492-6.
58. Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B, et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol 2012; 12: 144.
59. Hooper SJ, Crean S-J, Fardy MJ, Lewis MA, Spratt DA, Wade WG, et al. Amolecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol 2007; 56: 1651-9.
60. Mager D, Haffajee A, Devlin P, Norris C, Posner M, Goodson J. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005; 3: 27.
61. Hooper SJ, Crean SJ, Lewis MA, Spratt DA, Wade WG, Wilson MJ. Viable bacteria present within oral squamous cell carcinoma tissue. J Clin Microbiol 2006; 44: 1719-25.
62. Pushalkar S, Mane SP, Ji X, Li Y, Evans C, Crasta OR, et al. Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol 2011; 61: 269-77.
63. Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz EL, et al. Changes in abundance of oral microbiota associated with oral cancer. PLoS One 2014; 9: e98741.
64. Al-Hebshi NN, Nasher AT, Idris AM, Chen T. Robust species taxonomy assignment algorithm for 16S rRNA NGS reads: application to oral carcinoma samples. J Oral Microbiol 2015; 7: 28934, doi: http://dx.doi.org/10.3402/jom.v7.28934
65. Xie H, Onsongo G, Popko J, de Jong EP, Cao J, Carlis JV, et al. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics 2008; 7: 486-98.
66. Nakhjiri SF, Park Y, Yilmaz O, Chung WO, Watanabe K, El-Sabaeny A, et al. Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol Lett 2001; 200: 145-9.
67. Yilmaz Ö, Jungas T, Verbeke P, Ojcius DM. Activation of the phosphatidylinositol 3-kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas gingivalis. Infect Immun 2004; 72: 3743-51.
68. Mao S, Park Y, Hasegawa Y, Tribble GD, James CE, Handfield M, et al. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell Microbiol 2007; 9: 1997-2007.
69. Yao L, Jermanus C, Barbetta B, Choi C, Verbeke P, Ojcius D, et al. Porphyromonas gingivalis infection sequesters pro-apoptotic Bad through Akt in primary gingival epithelial cells. Mol Oral Microbiol 2010; 25: 89-101.
70. Moffatt CE, Lamont RJ. Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infect Immun 2011; 79: 2632-7.
71. Yilmaz Ö, Yao L, Maeda K, Rose TM, Lewis EL, Duman M, et al. ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell Microbiol 2008; 10: 863-75.
72. Groeger S, Domann E, Gonzales JR, Chakraborty T, Meyle J. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology 2011; 216: 1302-10.
73. Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget 2015; 6: 22613-23.
74. Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ, et al. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect 2008; 10: 122-8.
75. Pan C, Xu X, Tan L, Lin L, Pan Y. The effects of Porphyromonas gingivalis on the cell cycle progression of human gingival epithelial cells. Oral Dis 2014; 20: 100-8.
76. Zhou Y, Sztukowska M, Wang Q, Inaba H, Potempa J, Scott DA, et al. Noncanonical activation of beta-catenin by Porphyromonas gingivalis. Infect Immun 2015; 83: 3195-203.
77. Uitto V-J, Baillie D, Wu Q, Gendron R, Grenier D, Putnins EE, et al. Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect Immun 2005; 73: 1171-9.
78. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/b-catenin signaling via its FadA adhesin. Cell Host Microbe 2013; 14: 195-206.
79. Inaba H, Sugita H, Kuboniwa M, Iwai S, Hamada M, Noda T, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol 2014; 16: 131-45.
80. Inaba H, Amano A, Lamont RJ, Murakami Y. Involvement of protease-activated receptor 4 in over-expression of matrix metalloproteinase 9 induced by Porphyromonas gingivalis. Med Microbiol Immunol 2015; 204: 605-12.
81. Ha NH, Woo BH, Kim da J, Ha ES, Choi JI, Kim SJ, et al. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties. Tumour Biol 2015; 36: 9947-60.
82. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-99.
83. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014; 2014: 149185.
84. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013; 14: 207-15.
85. McCoy AN, Araujo-Perez F, Azcarate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS One 2013; 8: e53653.
86. Andrian E, Grenier D, Rouabhia M. In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun 2004; 72: 4689-98.
87. Narikiyo M, Tanabe C, Yamada Y, Igaki H, Tachimori Y, Kato H, et al. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci 2004; 95: 569-74.
88. Yumoto H, Nakae H, Yamada M, Fujinaka K, Shinohara C, Ebisu S, et al. Soluble products from Eikenella corrodens stimulate oral epithelial cells to induce inflammatory mediators. Oral Microbiol Immunol 2001; 16: 296-305.
89. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health 2006; 29: 245-54.
90. Seitz H, Gärtner U, Egerer G, Simanowski UA. Ethanol metabolism in the gastrointestinal tract and its possible consequences. Alcohol Alcohol Suppl 1994; 2: 157-62.
91. Seitz HK, Cho CH. Contribution of alcohol and tobacco use in gastrointestinal cancer development. Methods Mol Biol 2009; 472: 217-41.
92. Homann N, Tillonen J, Meurman JH, Rintamäki H, Lindqvist C, Rautio M, et al. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis 2000; 21: 663-8.
93. Väkeväinen S, Mentula S, Nuutinen H, Salmela K, Jousimies-Somer H, Färkkilä M, et al. Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis. Scand J Gastroenterol 2002; 37: 648-55.
94. Salaspuro MP. Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci 2003; 40: 183-208.
95. Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L, et al. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol 2007; 43: 181-6.
96. Muto M, Hitomi Y, Ohtsu A, Shimada H, Kashiwase Y, Sasaki H, et al. Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: implications for carcinogenesis in upper aerodigestive tract. Int J Cancer 2000; 88: 342-50.